Dexcom Reports First Quarter 2021 Financial Results

Go back to Dexcom Reports First Quarter 2021 Financial Results

DexCom (DXCM) Tops Q1 EPS by 3c

April 29, 2021 4:14 PM EDT

DexCom (NASDAQ: DXCM) reported Q1 EPS of $0.33, $0.03 better than the analyst estimate of $0.30. Revenue for the quarter came in at $505 million versus the consensus estimate of $484.23 million.

Dexcom is off to a great start in 2021, including several key advancements of our strategic... More